BAILEY DRYDEN: Open Payments
NPI 1710537345 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 81 payments from 7 companies in 2025. Trend: 2023 $1,781 · 2024 $1,015 · 2025 $1,290
Food & beverage: $1,290
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $316 |
| Axsome Therapeutics, Inc. | 14 | $233 |
| ABBVIE INC. | 11 | $220 |
| Collegium Pharmaceutical, Inc. | 16 | $208 |
| Corium, LLC | 11 | $143 |
| Otsuka America Pharmaceutical, Inc. | 8 | $138 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
Products named: CAPLYTA, Auvelity, VRAYLAR, Jornay PM, Azstarys, REXULTI, HETLIOZ, ABILIFY MAINTENA.
Industry payments across TN — which companies pay providers there.
